Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue (Tables)

Note 6 - Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

		*September 30, 2024*				*December 31, 2023*
Deferred extended maintenance and support		$	3,850				3,993
Deferred device and advances			160				169
Total deferred revenues			4,010				4,162
Less current portion			(2,039	)			(1,993	)
Deferred revenues, non-current		$	1,971			$	2,169

Beginning balance		$	4,162
Deferral of revenue			2,168
Recognition of deferred revenue			(2,320	)
Ending balance		$	4,010

Disaggregation of Revenue [Table Text Block]

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,096			$	24			$	3,120
Service and support			691				—				691
Subscriptions			123				—				123
Parts and other			177				18				195
		$	4,087			$	42			$	4,129

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,390			$	190			$	3,580
Service and support			726				—				726
Subscriptions			245				—				245
Parts and other			27				29				56
		$	4,388			$	219			$	4,607

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	9,337			$	351			$	9,688
Service and support			2,292				—				2,292
Subscriptions			413				—				413
Parts and other			388				54				442
		$	12,430			$	405			$	12,835

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	10,041			$	308			$	10,349
Service and support			2,092				—				2,092
Subscriptions			781				—				781
Parts and other			158				52				210
		$	13,072			$	360			$	13,432